Lungs
Urine
CNS
Abdomen
Skin
History
Tmax (rectal)
Resp symptoms
Rash
Seizures
Urine/stools
Pain
Exposures
PMH
Perinatal
Adjust age (chronologic age in weeks – [40 – gestational age in weeks])
Mother GBS status
Maternal fever/tachycardia/abdominal pain (chorioamnionitis)
Mother HSV
Birth weight/APGAR
Post-partum course
Immunocompromised (cancer, asplenia, HIV), history of infections/multiplications
Vaccinations
Meds (antipyretics, antibiotics)
Mother's medications if breastfeeding (may pass through breastmilk)
Allergies
Physical Exam
Alertness (AVPU)
ABCs
Airway patent/maintainable
Breathing (RR, O2sat, WOB, auscultation)
Circulation (BP, HR, cyanosis, cap refill, femoral pulses, distal pulses, auscultation)
Temp rectal
HEENT / hydration status
Neuro
Fontanelle
Pupils
Tone/Reflexes
Abdominal
MSK
Joints
Ambulation (limp)
Skin
Red Flags
Cyanosis, poor peripheral circulation
Petechial rash
Inconsolability
Parental and physician concern
CBC, CRP
Urinalysis and Urine culture
Blood culture
Consider
Procalcitonin
LP (cell count, culture, Gram stain, protein, glucose, and viral studies)
Optional in >1 month old and low risk (see below)
CXR
Optional if suspect bronchiolitis OR absence of resp sx and >2 months
Stool culture if diarrhea
NPA for respiratory virus (influenza)
Low Risk Invasive Bacterial Infection (IBI)
Using previously described predictions rules (Step-by-Step and PECARN), may consider avoiding LP/antibiotics in well-appearing 29-60 day old with
Rectal T<38.6 °C
UA negative (neg LE/NI with <5WBC on hpf)
Procalcitonin ≤0.5 ng/mL
ANC <4000/microL
CRP <20
Note: However these labs were rapidly available <60 minutes
Healthy, vaccinated, well-appearing, low-risk
UA
If negative, close out-patient follow-up
If positive, oral antibiotics with close outpatient follow-up
<3 years old, if fever with unclear source
>3 years old, consider testing if presence of dysuria, urinary frequency, hematuria, abdominal/back pain, daytime incontinence
Empiric IV antibiotics and fluids
<1 month
Ampicillin (100-200mg/kg/d IV divided q6h) + Cefotaxime 50mg/kg IV q8h or Gentamycin 2.5mg/kg IV q8h or Tobramycin 6mg/kg IV q24h with dose adjustments
>1month, urinary findings
Cefotaxime 50mg/kg IV q8h
1-3 months
Non-meningitic: Ceftriaxone 50mg/kg/day IV divided q12-24h
Meningitis: Ceftriaxone 100mg/kg/day IV divided q12-24h
Add ampicillin 100mg/kg IV q6g (3g max/dose) for Listeria or enterococcus concern
Add vancomycin 15mg/kg/dose IV q6h for MRSA if concern
Consider empiric antivirals (acyclovir), especially if suspect HSV meningitis
Antipyretic may help for prognostication and examination
Ibuprofen 10mg/kg TID
Acetaminophen 15mg/kg QID
Rule out Kawasaki
Fever ≥ 5 days (if any of the 4 below criteria present at any time during illness, diagnose on day 4 of illness)
Conjunctivitis (bilateral nonexudative)
Rash (polymorphic)
Adenopathy (Cervical lymph node >1.5cm)
Strawberry tongue (oral mucous membranes changes, also injected/fissured lips, injected pharynx)
Hands and feet edema (acute)/desquamation (convalescent)
Other useful findings: Redness/crust formation at BCG vaccination site (50% will have this)
Consider labs (WBC, platelet, AST, ALT, CRP, ESR, Urinalysis for pyuria, consider viral testing for alternative diagnoses)
Treat with ASA and IVIG to prevent coronary artery aneurysms
References:
NICE 2017. https://www.nice.org.uk/guidance/cg160
ACEP 2016. http://www.annemergmed.com/article/S0196-0644(16)00093-7/pdf
AAFP 2013. http://www.aafp.org/afp/2013/0215/p254.html
Pediatrics 2015. Step-by-Step Approach. http://pediatrics.aappublications.org/content/pediatrics/early/2016/07/01/peds.2015-4381.full.pdf
JAMA Pediatrics 2019. PECARN rule. https://www.ncbi.nlm.nih.gov/pubmed/30776077